Panda Surgical is a London-based medical device company building a novel handheld robotic system intended for confined-space neurosurgery. Its platform pairs the familiarity of manual tools with detachable, wristed robotic instruments as small as 3 mm in diameter, aiming to let surgeons perform more precise and complex brain and spine operations. Recent milestones include successful worldwide cadaver labs, animal trials, and the expansion of its patent portfolio. The company plans to apply its latest funding toward its first-in-human clinical investigation and continued product development. Leadership believes the technology can broaden global access to advanced surgical care by shrinking the cost and footprint of traditional robotics. Although still pre-revenue, Panda Surgical’s early clinical and technical validation has attracted both institutional and strategic clinician investors.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2025